# Chinese Medicine on Deferring Dialysis Initiation

Study · id `cardio:ct-nct02194946` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02194946](<https://clinicaltrials.gov/study/NCT02194946>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02194946

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 875 participants.

## Technical summary

Registry record NCT02194946. Non-randomized; no masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2020-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 875 participants (planned count; ClinicalTrials.gov record NCT02194946, source copy `cardio:ctgov-nct02194946-2019-12-26`, retrieved 2026-10-26)
- Start date: 2014-07 (registry gives no type) (ClinicalTrials.gov record NCT02194946, source copy `cardio:ctgov-nct02194946-2019-12-26`, retrieved 2026-10-26)
- Primary completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT02194946, source copy `cardio:ctgov-nct02194946-2019-12-26`, retrieved 2026-10-26)
- Completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT02194946, source copy `cardio:ctgov-nct02194946-2019-12-26`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02194946, source copy `cardio:ctgov-nct02194946-2019-12-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02194946-2019-12-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Chinese Medicine on Deferring Dialysis Initiation
- Acronym: C-MODDI
- Condition: End-Stage Renal Disease
- Intervention (Drug): CM therapies
- Intervention (Drug): CKD-related management
- Lead sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine
- Lead sponsor class: OTHER
- Collaborator: Ministry of Science and Technology of the People´s Republic of China
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine (`cardio:org-guangdong-provincial-hospital-of-traditional-chinese-befb6a`)
- Registry lists this organization as a collaborator: Ministry of Science and Technology of the People´s Republic of China (`cardio:org-ministry-of-science-and-technology-of-the-people-s-republic-dda658`)

## Provenance

Content hash: a765df843dcf56f4cb844038698b30f0e74cccfea2dd2663c64073ed61d6fad9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
